111 related articles for article (PubMed ID: 2421926)
21. Strain differentiation of polioviruses with monoclonal antibodies.
Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies against Schistosoma mekongi surface tegumental antigens.
Viyanant V; Gajanadana O; Upatham ES; Sobhon P; Kruatrachue M; Ahmed S; Ardseungnoen P
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):484-8. PubMed ID: 7512753
[TBL] [Abstract][Full Text] [Related]
23. Production of hybrid cell lines secreting monoclonal antibodies against poliovirus Type 2.
Guo R; Tang EH; Jiang YQ; Wen YL; Lu FM; Lin JY
Chin Med J (Engl); 1983 Sep; 96(9):669-74. PubMed ID: 6317298
[No Abstract] [Full Text] [Related]
24. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.
Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F
Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311
[TBL] [Abstract][Full Text] [Related]
25. [Monoclonal antibodies against Brunhilde strain of poliovirus type I].
Tang EH; Jian YQ; Wen YL; Lin JY; Guo R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Apr; 6(2):150-2. PubMed ID: 6100481
[No Abstract] [Full Text] [Related]
26. [Type-specific and strain-specific monoclonal antibody against type 1 poliovirus].
Gu FZ
Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):69-72. PubMed ID: 6305464
[No Abstract] [Full Text] [Related]
27. [Obtaining of new monoclonal antibodies against human immunoglobulins of class G, suitable for use in diagnostics of infectious diseases].
Halkin OIu; Nikolaienko IV; Raievs'ka HIe; Mykhaĭlenko LP; Kostenko OH; Spivak MIa
Mikrobiol Z; 2005; 67(6):40-8. PubMed ID: 16493884
[TBL] [Abstract][Full Text] [Related]
28. Preliminary studies on antigenic variation of poliovirus using neutralizing monoclonal antibodies.
Guo R; Tang EH; Wang H; Yang XF; Liu MY; Qin HX; Li QH; Zhuang JY; Liu KM
J Gen Virol; 1987 Apr; 68 ( Pt 4)():989-94. PubMed ID: 3033136
[TBL] [Abstract][Full Text] [Related]
29. [Antigenic analysis of 100 strains of poliomyelitis type I virus by monoclonal antibody].
Gu FZ
Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):265-7. PubMed ID: 3004840
[No Abstract] [Full Text] [Related]
30. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
[TBL] [Abstract][Full Text] [Related]
31. Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.
Sawyer LA; Wood D; Ferguson M; Crainic R; Beuvery EC; McInnis J; Albrecht P
Biologicals; 1997 Sep; 25(3):299-306. PubMed ID: 9324998
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
Uhlig H; Rutter G; Dernick R
Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
[TBL] [Abstract][Full Text] [Related]
33. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
34. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
[TBL] [Abstract][Full Text] [Related]
35. Antigen chimaeras of poliovirus as potential new vaccines.
Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
[TBL] [Abstract][Full Text] [Related]
36. Comparisons of poliovirus antigen measurements in vitro and in small animals.
von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
[No Abstract] [Full Text] [Related]
37. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
38. Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies.
Damle RG; Yeolekar LR; Rao BL
Acta Virol; 1998 Dec; 42(6):389-95. PubMed ID: 10358745
[TBL] [Abstract][Full Text] [Related]
39. Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).
Rezapkin G; Dragunsky E; Chumakov K
Biologicals; 2005 Mar; 33(1):17-27. PubMed ID: 15713553
[TBL] [Abstract][Full Text] [Related]
40. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
